Results 131 to 140 of about 1,121 (144)

Exploring the role of aMAP and Toronto score: beyond diagnosis to prognosis

Digestive and Liver Disease
A. Cespiati, D. Smith, C. Bertelli, R. Lombardi, A.L. Fracanzani   +4 more
openaire   +1 more source

P54 Historic aMAP scores at one-year and 5-years prior to diagnosis of Hepatocellular Carcinoma (HCC) show significant differences between male and female patients

Poster presentations, 2023
Avisnata Das, Nicole George, Benjamin Giles, Joanna Dowman, Andrew Fowell, Richard Aspinall   +5 more
openaire   +1 more source

IDDF2022-ABS-0073 HCC surveillance program in a nurse-led clinic: assessing adherence to guidelines and possibility of reducing pressure on services by applying AMAP score

Clinical Hepatology, 2022
Mohamed Elnagar, Muhammad Saleem, Alison Beard, Samantha Whyld, Andrew Austin   +4 more
openaire   +1 more source

OP13 High-risk aMAP scores are present in a majority of Hepatocellular Carcinoma (HCC) patients not undergoing prior routine ultrasound-based screening, at both one and five years before HCC diagnosis

Abstracts, 2022
Avisnata Das, Benjamin Giles, Joanna Dowman, Andrew Fowell, Richard Aspinall   +4 more
openaire   +1 more source

The intermediary effect of intelligent Amap-related traffic efficiency on haze pollution

Transportation Research, Part E: Logistics and Transportation Review, 2023
Juying Zeng
exaly  

WED-201 aMAP score effectively stratifies HCC risk in the steatotic liver disease population in the UK biobank

Journal of Hepatology
Yaru Shi, Wenxin Xu, Ning Yu, Zhihong Liu, Ya Xu, Jinlin Hou, Rong Fan   +6 more
openaire   +1 more source

P224 Evaluating the performance of aMAP scores in predicting hepatocellular carcinoma development in cirrhosis patients over a three-year period

Posters
Arash Akhavan Rezayat, Avisnata Das, Benjamin Giles, Kirsty Fancey, Karen Gamble, Michelle Padgett, Aqeel Jamil, Joanna Dowman, Andrew Fowell, Richard Aspinall   +9 more
openaire   +1 more source

THU-464 aMAP score predicts progression-free survival in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma

Journal of Hepatology
Mathew Vithayathil, Antonio D'Alessio, Claudia Fulgenzi, Ciro Celsa, Giulia Manfredi, Naoshi Nishida, Martin Schoenlein, Johann von Felden, Kornelius Schulze, Henning Wege, Anwaar Saeed, Brooke Wietharn, Hannah Hildebrand, Linda Wu, Celina Ang, Thomas U. Marron, Arndt Weinmann, Peter R. Galle, Dominik Bettinger, Chun-yen Lin, Arndt Vogel, Bernhard Scheiner, Pei-Chang Lee, Yi-Hsiang Huang, Suneetha Amara, Mahvish Muzaffar, Abdul Rafeh Naqash, Valentina Zanuso, Tiziana Pressiani, Giuseppe Cabibbo, Andrea Dalbeni, Matthias Pinter, Amit Singal, Hong Jae Chon, Alessio Cortellini, Masatoshi Kudo, Lorenza Rimassa, David J. Pinato, Rohini Sharma   +38 more
openaire   +1 more source

AMAP, the alleged non-toxic isomer of acetaminophen, is toxic in rat and human liver

Archives of Toxicology, 2012
Mackenzie Hadi, Sanja Dragovic, Rachel P L Van Swelm   +2 more
exaly  

Analytical methods, quality assurance and quality control used in the Greenland AMAP programme

Science of the Total Environment, 2000
Gert Åsmund, M Cleemann
exaly